PASTUCHA, Matěj, Martin POTRUSIL, Zdeněk FARKA and Peter ŠEBEJ. Near-infrared Polymethine Dyes for Targeted Biomarker Detection. In XXth Interdisciplinary Meeting of Young Researchers and Students in the Field of Chemistry, Biochemistry, Molecular Biology, and Biomaterials. 2020. ISSN 2336-7202.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Near-infrared Polymethine Dyes for Targeted Biomarker Detection
Authors PASTUCHA, Matěj, Martin POTRUSIL, Zdeněk FARKA and Peter ŠEBEJ.
Edition XXth Interdisciplinary Meeting of Young Researchers and Students in the Field of Chemistry, Biochemistry, Molecular Biology, and Biomaterials, 2020.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
Organization unit Faculty of Science
ISSN 2336-7202
Changed by Changed by: Mgr. Matěj Pastucha, Ph.D., učo 356629. Changed: 9/11/2020 11:34.
Abstract
Fluorescent dyes have a wide scope of use in life-sciences and medicine, most commonly as imaging agents, either alone, or in connection with antibodies in immunofluorescence experiments. Biological tissues absorb visible light and a tissue-transparent window (TTW) in the near-infrared (NIR) region is preferred for imaging purposes. This is particularly true in the fluorescence image-guided surgery. Polymethine dyes are good candidates for applications in the TTW and their properties can be tuned by changes in the polymethine chain length and substituents. We chose the indocyanine green (ICG) as an initial model as it is the only NIR dye certified by the FDA for use in clinical medicine. It is usually used as a dye with very limited selectivity, but when conjugated to an antibody, it can also be used for specific visualization of a biomarker of interest. We chose the carbohydrate antigen (CA) 19-9 as a promising target because it is already successfully used in the diagnosis and monitoring of treatment outcome in patients with pancreatic cancer. First, we labeled the mouse anti CA 19-9 antibody with the ICG NHS ester. The conjugate was successfully tested in a microtiter plate-based fluorescence immunoassay. Testing of the conjugate for detection of CA 19-9 in cell lines and tissue sections follows. We aim to develop a platform for assessing the performance of the newly synthesized polymethine fluorescent labels in complex biological systems.
Links
GJ20-30004Y, research and development projectName: Nové strukturní motivy pro rozšíření možností lineárních polymethinových barviv
Investor: Czech Science Foundation
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 31/7/2024 00:17